Big Pharma's Q3 2010 Earnings Report

The third quarter was a mixed bag for Big Pharma. After recalls and lawsuits, many companies took hits to their quarterly earnings, but most still came ahead of analysts' expectations. For highlights of the ups and downs of the top 10 companies in pharma (according to 2009 revenue), check out our list, or click through to a specific company.

1. Johnson & Johnson
2. Pfizer
3. Roche
4. GlaxoSmithKline
5. Novartis

6. Sanofi-Aventis
7. AstraZeneca
8. Abbott Laboratories
9. Merck
10. Bayer Healthcare

Read more on

Suggested Articles

Pennsylvania's Supreme Court revived thousands of lawsuits alleging the antipsychotic med Risperdal caused males to develop breasts.

In the asthma biologics race, there doesn't appear to be a clear favorite among Xolair, Dupixent, Fasenra and Nucala for a group of pulmonologists.

Analysts are cautiously optimistic Amgen's $13.4 billion purchase of Celgene's psoriasis blockbuster Otezla will pay off.